| Literature DB >> 21234378 |
Patricia Ewing1, Diana C Otczyk, Stefano Occhipinti, Jennelle M Kyd, Maree Gleeson, Allan W Cripps.
Abstract
This study investigated the effect of attending pre-school on mucosal immunity. Children 3.5 to 5 years of age who attended pre-school were observed for a 10 month period. Demographic information was collected on previous childcare experiences, the home environment and clinical information relating to the child and the family. A daily illness log was kept for each child. A multivariate longitudinal analysis of the relation between immunoglobulins in saliva and age, gender, childcare experience, pre-school exposure, number of siblings, environmental tobacco smoke (ETS), atopy and hospitalisation was conducted. There was a positive association of higher IgA levels with the winter season and with children being older than 4 years (P < .001), having attended childcare prior to commencing pre-school (P < .05), and having been exposed to ETS at home (P < .05). Lower IgA levels were associated with being atopic (P < .05). Higher IgG levels were associated with exposure to ETS (P < .001), while lower levels were associated to having atopy. Higher IgM levels were associated with previous childcare experience (P < .01) whilst having been hospitalised was associated with having low salivary IgM levels (P < .01). Lagged analyses demonstrated that immunological parameters were affected by the number of respiratory infections in the preceding 2 months.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21234378 PMCID: PMC3017893 DOI: 10.1155/2010/196785
Source DB: PubMed Journal: Clin Dev Immunol ISSN: 1740-2522
Demographic characteristics of the study population (n = 37).
| Variables | Definition and description | Distribution |
|---|---|---|
|
| ||
|
| ||
| Age | ≤4 years of age | 15 (45.5%) |
| >4 years of age | 22 (54.5%) | |
| Gender | Female | 21 (56.8%) |
| Male | 16 (43.2%) | |
| Having attended childcare previously | No | 8 (21.6%) |
| Yes | 29 (78.4%) | |
| No. of days at pre-school | Low—<2 days/week for <1 year | 13 (35.1%) |
| High—≥2 days/week for ≥1 year | 24 (64.9%) | |
|
| ||
|
| ||
| Having siblings | No | 16 (43.3%) |
| No. of siblings | Yes | 21 (56.7%) |
| 2.51a (0.77) | ||
| ETS exposure in home | No | 23 (63.2%) |
| Yes | 14 (37.8%) | |
|
| ||
|
| ||
| Having atopy | No | 31 (83.8%) |
| Yes | 6 (16.2%) | |
| Having been hospitalised | No | 23 (62.2%) |
| Yes | 14 (37.8%) | |
aThe arithmetic mean of the number of siblings (and standard deviation) is reported for this covariate.
Regression coefficients (standard errors in parentheses) for multilevel regressions on each immunological outcome.
| Immunological outcome | ||||
|---|---|---|---|---|
| Predictor | IgA | IgG | IgM |
|
| Time effect linear | 0.172* (0.071) | −0.103 (0.109) | −0.021 (0.121) | −0.058 (0.099) |
| Time effect curvilinear | −0.043* (0.017) | 0.021 (0.026) | 0.018 (0.029) | 0.020 (0.024) |
| Aged older than 4 years | 0.271*** (0.081) | 0.152 (0.132) | 0.3218 (0.139) | 0.091 (0.119) |
| Female | −0.035 (0.089) | 0.159 (0.147) | 0.120 (0.155) | −0.279* (0.132) |
| Previous childcare experience | 0.185* (0.092) | −0.040 (0.150) | 0.473** (0.157) | 0.329* (0.136) |
| High pre-school exposure | −0.166 (0.090) | −0.317* (0.146) | −0.211 (0.154) | 0.401** (0.132) |
| Having siblings | 0.028 (0.056) | −0.107 (0.092) | 0.130 (0.097) | 0.070 (0.084) |
| ETS exposure | 0.205* (0.082) | 0.453*** (0.134) | 0.087 (0.141) | −0.075 (0.121) |
| Having atopy | −0.216* (0.103) | −0.372* (0.168) | −0.025 (0.177) | 0.199 (0.151) |
| Having been hospitalised | −0.002 (0.096) | 0.151 (0.157) | −0.412* (0.165) | −0.125 (0.141) |
Note. Outcomes are logtransformed.
Significance of associations: *P < .05; **P < .01; ***P < .001.
Salivary immunological parameters, reported as geometric mean and 95% confidence interval (CI), at each assessment point during the pre-school year.
| Saliva collection time | |||||
|---|---|---|---|---|---|
|
| |||||
| 1 | 2 | 3 | 4 | 5 | |
| February (summer end) geometric mean (95% CI) | April (autumn) geometric mean (95% CI) | July (winter) geometric mean (95% CI) | September (spring) geometric mean (95% CI) | December (presummer) geometric mean (95% CI) | |
| IgA (mg/L) | 21.83 (18.99–25.10) | 21.07 (18.20–24.40) | 30.27 (25.72–35.61) | 20.65 (17.48–24.39) | 22.12 (18.85–25.97) |
| IgG (mg/L) | 2.99 (2.34–3.82) | 2.89 (2.29–3.66) | 2.32 (1.86–2.91) | 3.03 (2.26–4.06) | 2.87 (2.16–3.82) |
| IgM (mg/L) | 0.87 (0.64–1.17) | 0.96 (0.73–1.26) | 0.81 (0.63–1.04) | 1.04 (0.83–1.31) | 1.10 (0.81–1.48) |
|
| 0.11 (0.09–0.14) | 0.08 (0.06–0.09) | 0.10 (0.09–0.12) | 0.12 (0.09–0.16) | 0.11 (0.09–0.13) |